Osborne Clarke advised Creo Europe on the deal. Micro-Tech Nanjing, a Chinese producer of minimally invasive medical devices, acquired a controlling stake (51%) of Creo Medical...
Micro-Tech’s Acquisition Of 51% Stake In Creo Medical
Wilmington Plc’s £48.5 Million Sale Of Its European Healthcare Business
Osborne Clarke has advised Wilmington Plc on the deal. Wilmington plc, the UK listed provider of data, information, education and training in the global Governance, Risk...